<DOC>
	<DOC>NCT00714415</DOC>
	<brief_summary>The purpose of this observational study is to describe the incidence of adverse events among patients treated with BeneFix速 in usual health care settings in Germany.</brief_summary>
	<brief_title>Registry For Patients Treated With BeneFix In Usual Care Setting In Germany</brief_title>
	<detailed_description>Non-interventional study: subjects to be selected according to the usual clinical practice of their physician</detailed_description>
	<mesh_term>Hemophilia B</mesh_term>
	<criteria>Patients with hemophilia B already receiving or starting treatment with reformulated BeneFIX速. Patients with hemophilia B treated with a product other than BeneFIX速. Inclusion in the ongoing prospective registry of European hemophilia B patients using BeneFIX速.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>